PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,148,000 | +26.2% | 41,252 | -0.5% | 1.04% | +28.5% |
| Q4 2021 | $2,494,000 | +6.9% | 41,452 | -0.5% | 0.81% | -4.4% |
| Q3 2021 | $2,334,000 | -7.9% | 41,680 | -0.2% | 0.84% | -6.8% |
| Q2 2021 | $2,533,000 | -13.8% | 41,751 | -0.5% | 0.91% | -18.4% |
| Q1 2021 | $2,940,000 | +17.1% | 41,951 | 0.0% | 1.11% | +12.9% |
| Q4 2020 | $2,510,000 | -3.7% | 41,951 | -3.2% | 0.98% | -6.7% |
| Q3 2020 | $2,606,000 | +14.0% | 43,351 | -0.5% | 1.05% | +7.4% |
| Q2 2020 | $2,285,000 | +56.0% | 43,551 | -0.3% | 0.98% | +35.1% |
| Q1 2020 | $1,465,000 | -26.2% | 43,681 | -0.4% | 0.73% | -9.4% |
| Q4 2019 | $1,986,000 | +17.1% | 43,845 | -1.6% | 0.80% | +7.8% |
| Q3 2019 | $1,696,000 | -19.7% | 44,545 | -8.3% | 0.74% | -20.8% |
| Q2 2019 | $2,112,000 | +16.7% | 48,573 | +2.2% | 0.94% | +11.1% |
| Q1 2019 | $1,810,000 | -12.3% | 47,548 | -1.0% | 0.84% | -22.9% |
| Q4 2018 | $2,065,000 | -11.6% | 48,008 | +1.0% | 1.09% | +1.6% |
| Q3 2018 | $2,335,000 | +50.0% | 47,533 | -2.2% | 1.08% | +41.2% |
| Q2 2018 | $1,557,000 | +1.2% | 48,588 | -1.6% | 0.76% | -1.0% |
| Q1 2018 | $1,538,000 | -33.3% | 49,388 | -2.2% | 0.77% | -32.4% |
| Q4 2017 | $2,305,000 | +29.5% | 50,493 | +6.5% | 1.14% | +21.8% |
| Q3 2017 | $1,780,000 | -20.3% | 47,393 | +1.3% | 0.94% | -22.5% |
| Q2 2017 | $2,232,000 | +11.9% | 46,793 | +7.0% | 1.21% | +8.0% |
| Q1 2017 | $1,995,000 | +54.2% | 43,748 | +9.2% | 1.12% | +42.7% |
| Q4 2016 | $1,294,000 | -5.1% | 40,053 | +0.6% | 0.78% | -8.5% |
| Q3 2016 | $1,363,000 | +74.1% | 39,830 | +71.7% | 0.86% | +76.0% |
| Q2 2016 | $783,000 | -36.0% | 23,200 | +0.4% | 0.49% | -38.3% |
| Q1 2016 | $1,224,000 | -20.5% | 23,100 | +15.2% | 0.79% | -20.2% |
| Q4 2015 | $1,540,000 | +81.4% | 20,050 | -2.9% | 0.99% | +71.7% |
| Q3 2015 | $849,000 | – | 20,650 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |